http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0535663-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66467fe5b0acf469afb972f300bcfb87 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54393 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate | 1992-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6058d98bd49d6d470f0bc95e6d55a872 |
| publicationDate | 1993-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0535663-A2 |
| titleOfInvention | Novel antibodies useful for the detection of benign and malignant tumors |
| abstract | Novel anti-non- ras -p21 antibodies with a particular N-terminal aminoacids sequence of two peptides derived from the non- ras -p21 protein are described. These antibodies were found to be able to detect malignant diseases by their reaction with biological fluids of patients with tumors. The method for this detection uses a modified ELISA procedure.This ELISA procedure with the novel anti-non- ras -p21 antibodies were found to be useful for clinical monitoring of patients with different types of tumors, such as urogenital and gastrointestinal, as well as malignant lymphomas, some of which have no available tumor marker. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0662612-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1348961-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6300081-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1348961-A4 |
| priorityDate | 1991-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.